STOCKHOLM (AFX) Stockholm Stock Exchange began as with the major European venues the new trading week with a decline, but returned after about 45 minutes, plus support including the major banks.
Best fared otherwise, the commodities sector since both metals and oil traded above the previous week’s levels.
In the Stockholm Stock Exchange Blue Chip index was SSAB brightest star in the light of expectations of new steel tariffs, while Fingerprint Cards, SCA and AstraZeneca weighed.
at 10:20 o’clock was the Stockholm Stock Exchange OMXS30 index down 0.8 percent to 1,375 notes. Shares for about 2.7 billion had then traded on the Stockholm Stock Exchange.
The development is less positive figures in Friday’s trading on Wall Street and a slightly greater optimism on the Chinese stock markets on Monday since inflation data indicated continued economic growth. In commodity markets, metal prices were largely unchanged, while oil fell from Friday’s highest peaks.
SSAB A shares rose 3.6 percent after Friday evening’s information about SSAB and other North American plate producers formally requested protective tariffs. RBC identifies SSAB as one of the winners of the new tariffs will become a reality.
Although the mining company Boliden began the day strongly, with an increase of 2.2 percent. Base metal prices were largely unchanged after the Asian trading has risen. Gold price recorded nearly 1 percent up.
In the sector rose gold company Semafo 3.3 percent and Lundin Mining barely 2 percent. Most, however, lifted Lundin Gold, up 9 percent, having rushed more than 14 percent of North American trading on Friday. The company has set itself unsympathetic to the sudden increase.
Oil prices rose about 5 percent on Friday, but fell back slightly on Monday morning. Lundin Petroleum was up marginally, while Enquest rose nearly 4 percent, supported by a recommendation hike by Pareto.
The big banks lifted after a hesitant start. SHB, Nordea and SEB rose all around 1.4 percent, while Swedbank came slightly after.
Smaller increases were also noted for a number of engineering companies.
Outside the large cap index declined pharmaceutical company Sobi 1.2 percent after data from Reuters that Sobi US partner Biogen considering selling its blödarsjukarättigheter. Biogen has previously, mainly together with Pfizer, has been considered a possible buyer of Sobi precisely because blödarsjukaprojekten.
In the same direction went Diamyd, which dropped nearly 3 percent. The company gets a new CEO Ulf Hannelius.
The upside was the contrast of CellaVision, which received a buy recommendation in Dagens Industri. Shares lifted over 11 percent.
Precise Biometric advanced 7 percent after having announced that it has won a framework agreement on Tactivo from the US Department of Defense. Contract value can amount to a maximum of $ 3.1 million for a base period of one year, with an option for another two years.
Technology Company Plejd debuted on AktieTorget with a price increase of nearly 90 percent compared to the issue price 6:35 SEK .
Graph: Stockholm Stock Exchange OMXS30 index Monday, april 11
Source: Infront
Direkt
No comments:
Post a Comment